Ixaltis SA

Ixaltis develops pharmaceutical products for the treatment of genitourinary and renal diseases. The Company focuses on licensing and acquiring clinical-stage compounds, as well as conducting clinical research and trials for urogenital tract disorders. Ixaltis SA serves patients in the United States, Europe, and France.